Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jon Røikjær Henriksen"'
Autor:
Jon Røikjær Henriksen, Line Nederby, Frede Donskov, Marianne Waldstrøm, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-9 (2020)
Abstract Purpose Biomarkers are needed to guide treatment decisions in recurrent ovarian cancer, as a high proportion of patients do not benefit from treatments. Data on immune subsets in patients receiving chemotherapy are scarce. We investigated th
Externí odkaz:
https://doaj.org/article/fb7aa638f37d4fd7b7004e3d055162c6
Autor:
Luka Tandaric, Jon Røikjaer Henriksen, Liv Cecilie Vestrheim Thomsen, René Depont Christensen, Marianne Waldstrøm, Johanna Mäenpää, Henrik Roed, Kristina Lindemann, Katrin Kleinmanns, Annika Auranen, Emmet McCormack, Sanne Lindberg, Kristine Madsen, Line Bjørge, Mansoor Raza Mirza
Publikováno v:
Late breaking abstracts.
Autor:
Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm, Jon Røikjær Henriksen, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1766
Faaborg, L, Andersen, R F, Waldstrøm, M, Henriksen, J R, Adimi, P, Jakobsen, A & Steffensen, K D 2022, ' Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer ', Cancers, vol. 14, no. 7, 1766 . https://doi.org/10.3390/cancers14071766
Faaborg, L, Andersen, R F, Waldstrøm, M, Henriksen, J R, Adimi, P, Jakobsen, A & Steffensen, K D 2022, ' Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer ', Cancers, vol. 14, no. 7, 1766 . https://doi.org/10.3390/cancers14071766
Methylated Homeobox A9 circulating tumor DNA (meth-HOXA9) has been suggested as a blood-based biomarker in epithelial ovarian cancer (EOC), although its prognostic significance remains unproven. The aim of the present study was to investigate the pro
Autor:
Line Nederby, Marianne Waldstrøm, Karina Dahl Steffensen, Jon Røikjær Henriksen, Frede Donskov, Anders Jakobsen, Parvin Adimi
Publikováno v:
Henriksen, J R, Nederby, L, Donskov, F, Waldstrøm, M, Adimi, P, Jakobsen, A & Dahl Steffensen, K 2020, ' Blood natural killer cells during treatment in recurrent ovarian cancer ', Acta Oncologica, vol. 59, no. 11, pp. 1365-1373 . https://doi.org/10.1080/0284186X.2020.1791358
Objective: Recent research indicated favorable prognostic impact of intratumoral natural killer (NK) cells in ovarian carcinoma (OC). The role of NK cells during chemotherapy in OC is unknown. We investigated impact of NK cells in OC patients treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e01ab98b7f9de21c2815c2555926c112
https://pure.au.dk/portal/da/publications/blood-natural-killer-cells-during-treatment-in-recurrent-ovarian-cancer(2a809f08-047e-4d6a-bede-c116c8b4b6f9).html
https://pure.au.dk/portal/da/publications/blood-natural-killer-cells-during-treatment-in-recurrent-ovarian-cancer(2a809f08-047e-4d6a-bede-c116c8b4b6f9).html
Autor:
Frede Donskov, Karina Dahl Steffensen, Jon Røikjær Henriksen, Marianne Waldstrøm, Mette Hjortkjær, Christina Braad Petersen, Anders Jakobsen
Publikováno v:
Henriksen, J R, Donskov, F, Waldstrøm, M, Jakobsen, A, Hjortkjaer, M, Petersen, C B & Dahl Steffensen, K 2020, ' Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma ', Acta Oncologica, vol. 59, no. 6, pp. 652-659 . https://doi.org/10.1080/0284186X.2019.1711173
Introduction: The aim of the present study was to investigate the prognostic impact of intratumoral cytotoxic T cells, Natural Killer (NK) cells, neutrophils and PD-L1 expression in patients with epithelial ovarian cancer. Methods: All patients diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb698834abb4df50dca6122802d8eac2
https://findresearcher.sdu.dk:8443/ws/files/169362898/Manuscript.Acta.15.12.19.pdf
https://findresearcher.sdu.dk:8443/ws/files/169362898/Manuscript.Acta.15.12.19.pdf
Autor:
Anders Jakobsen, Karina Dahl Steffensen, Jon Røikjær Henriksen, Parvin Adimi, Marianne Waldstrøm, Frede Donskov, Line Nederby
Publikováno v:
Journal of Ovarian Research
Henriksen, J R, Nederby, L, Donskov, F, Waldstrøm, M, Adimi, P, Jakobsen, A & Steffensen, K D 2020, ' Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy ', Journal of Ovarian Research, vol. 13, no. 1, 59 . https://doi.org/10.1186/s13048-020-00661-4
Henriksen, J R, Nederby, L, Donskov, F, Waldstrøm, M, Adimi, P, Jakobsen, A & Steffensen, K D 2020, ' Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy ', Journal of Ovarian Research, vol. 13, 59 . https://doi.org/10.1186/s13048-020-00661-4
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-9 (2020)
Henriksen, J R, Nederby, L, Donskov, F, Waldstrøm, M, Adimi, P, Jakobsen, A & Steffensen, K D 2020, ' Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy ', Journal of Ovarian Research, vol. 13, no. 1, 59 . https://doi.org/10.1186/s13048-020-00661-4
Henriksen, J R, Nederby, L, Donskov, F, Waldstrøm, M, Adimi, P, Jakobsen, A & Steffensen, K D 2020, ' Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy ', Journal of Ovarian Research, vol. 13, 59 . https://doi.org/10.1186/s13048-020-00661-4
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-9 (2020)
Purpose Biomarkers are needed to guide treatment decisions in recurrent ovarian cancer, as a high proportion of patients do not benefit from treatments. Data on immune subsets in patients receiving chemotherapy are scarce. We investigated the impact
Autor:
Jon Røikjær Henriksen, Line Nederby, Frede Donskov, Marianne Waldstrøm, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Publikováno v:
Henriksen, J R, Nederby, L, Donskov, F, Waldstrøm, M, Adimi, P, Jakobsen, A & Dahl Steffensen, K 2019, ' Blood natural killer cells as a new, independent prognostic factor in recurrent ovarian cancer ', Danish Cancer Research Days, Odense, Denmark, 29/08/2019-30/08/2019 .
University of Southern Denmark
University of Southern Denmark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0fbbe1cd3ba2c48fcd077b7269f1a958
https://portal.findresearcher.sdu.dk/da/publications/f6e75cd4-f9a0-40ff-ac2d-31da8808acd0
https://portal.findresearcher.sdu.dk/da/publications/f6e75cd4-f9a0-40ff-ac2d-31da8808acd0
Autor:
Line Nederby, Karina Dahl Steffensen, Ahmed Hussein Zedan, Anders Jakobsen, Inge Mejlholm, Jon Røikjær Henriksen, Louise Raunkilde, Lars Henrik Jensen, Caroline Brenner Thomsen, Torben Hansen
Publikováno v:
Hansen, T F, Nederby, L, Zedan, A H, Mejlholm, I, Henriksen, J R, Dahl Steffensen, K, Thomsen, C B, Raunkilde, L, Jensen, L H & Jakobsen, A 2019, ' Correlation between natural killer cell activity and treatment effect in patients with disseminated cancer ', Journal of Clinical Oncology, vol. 36, no. 15 Supplement, 12029 . https://doi.org/10.1200/jco.2018.36.15_suppl.12029
Translational Oncology, Vol 12, Iss 7, Pp 968-972 (2019)
Hansen, T F, Nederby, L, Zedan, A H, Mejlholm, I, Henriksen, J R, Dahl Steffensen, K, Thomsen, C B, Raunkilde, L, Jensen, L H & Jakobsen, A 2019, ' Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer ', Translational Oncology, vol. 12, no. 7, pp. 968-972 . https://doi.org/10.1016/j.tranon.2019.04.002
Translational Oncology
Translational Oncology, Vol 12, Iss 7, Pp 968-972 (2019)
Hansen, T F, Nederby, L, Zedan, A H, Mejlholm, I, Henriksen, J R, Dahl Steffensen, K, Thomsen, C B, Raunkilde, L, Jensen, L H & Jakobsen, A 2019, ' Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer ', Translational Oncology, vol. 12, no. 7, pp. 968-972 . https://doi.org/10.1016/j.tranon.2019.04.002
Translational Oncology
INTRODUCTION: The aim of the present study was to analyze the possible correlation between Natural Killer (NK) cell activity as measured by the NK Vue assay and treatment efficacy in patients with disseminated cancer. MATERIALS AND METHODS: The study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5255d5f69905283518256339a1d9ef
https://portal.findresearcher.sdu.dk/da/publications/963fc894-d340-46e8-9990-55168a8ea2ad
https://portal.findresearcher.sdu.dk/da/publications/963fc894-d340-46e8-9990-55168a8ea2ad
Autor:
Anders Jakobsen, Jon Røikjær Henriksen, Mette Hjortkjær, Karina Dahl Steffensen, Marianne Waldstrøm, Caroline Brenner Thomsen, Frede Donskov, Christina Braad Petersen
Publikováno v:
Henriksen, J, Donskov, F, Waldstrom, M, Hjortkjaer, M, Petersen, C B, Thomsen, C B, Jakobsen, A K M & Steffensen, K D 2019, ' Tissue immune response in epithelial ovarian carcinoma ', Journal of Clinical Oncology, vol. 37, no. 15 Supplement, 2625, pp. 2625-2625 . https://doi.org/10.1200/JCO.2019.37.15suppl.2625
2625 Background: Epithelial ovarian cancer (EOC) is a highly malignant disease with a fatal outcome for most patients. During recent years immunological mechanisms have proven important in relation to the treatment and prognosis of cancer, but within
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78038e88d8731aa0956f2aa0a6cb39e1
https://portal.findresearcher.sdu.dk/da/publications/055988ce-656d-4c20-aa07-01c4a77e9ca2
https://portal.findresearcher.sdu.dk/da/publications/055988ce-656d-4c20-aa07-01c4a77e9ca2
Autor:
Torben Hansen, Troels Bechmann, Erik Hugger Jacobsen, Ahmed Zedan, Inge Mejlholm, Jon Røikjær Henriksen, Karina Dahl Steffensen, Caroline Emilie Brenner Thomsen, Louise Raunkilde, Lars Henrik Jensen, Anders Jakobsen
Publikováno v:
Hansen, T F, Bechmann, T, Jacobsen, E H, Zedan, A, Mejlholm, I, Henriksen, J R, Dahl Steffensen, K, Brenner Thomsen, C E, Raunkilde Larsen, L, Jensen, L H & Jakobsen, A 2017, ' Monitoring the effect of cytostatic treatment by immune activity ', Annals of Oncology, vol. 28, no. Suppl. 5, 1644P, pp. 578 . < http://www.esmo.org/content/download/117241/2057634/file/ESMO-2017-Abstract-Book.pdf >
University of Southern Denmark
University of Southern Denmark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::718c25b06c3ccce5c13fd1502e4fd454
http://www.esmo.org/content/download/117241/2057634/file/ESMO-2017-Abstract-Book.pdf
http://www.esmo.org/content/download/117241/2057634/file/ESMO-2017-Abstract-Book.pdf